Archival Presentation Notice: This article modernizes the multimedia presentation “Hip Resurfacing: Failure Risk Factors After 25 Years Follow-Up” originally presented by Dr. E.J. Yue, Dr. G.P. Duffy, M.G. Heckman, Dr. M.J. O’Connor, and Dr. Miguel E. Cabanela (Mayo Clinic, Rochester, MN) at the International Congress for Joint Reconstruction (ICJR, Orlando, FL). The historical Flash lecture has been reconstructed into the synchronized video slide presentation above, with the original file preserved in the digital archives (hip_resurfacing_arthroplasty_cabanela.swf).
1. High-Yield Summary
- Catastrophic Long-Term Attrition of First-Generation Resurfacing: The landmark Mayo Clinic 25-year survivorship analysis of first-generation metal-on-polyethylene hip resurfacing (1977–1982) demonstrated an overall implant survival rate of only 73% at 5 years, 34% at 10 years, and 8% at 25 years, representing a cumulative 92% revision burden and a median implant survival of only 7.9 years.
- The “Resurfacing Paradox”: Early clinical success was deceptive. Patients achieved outstanding short-term pain relief and functional restoration (Harris Hip Score surging from a preoperative mean of 58.7 to 96.7 at one year), only to experience catastrophic functional collapse (dropping to a mean score of 61.0 prior to revision) driven by progressive osteolysis and aseptic loosening.
- Predominant Failure Modes: Aseptic loosening accounted for 93.8% of all revisions (60 of 64 revised patients). Detailed institutional surgical re-exploration revealed that femoral component failure (42.2%) occurred at least as frequently as isolated acetabular cup loosening (28.9%) or dual-component failure (28.9%). Acute femoral neck fractures accounted for 4% of early failures.
- Statistically Significant Risk Factors: Cox proportional hazards modeling identified patient age ≤ 40 years, female sex, and implant design (THARIES displaying significantly earlier and steeper failure curves than the Indiana Conservative Hip) as the primary independent determinants of premature failure. Conversely, body mass index, primary pathology, implant size, neck-shaft angle, femoral offset, and surgical learning curve did not correlate with implant longevity.
- Enduring Lessons for Modern Arthroplasty: While second-generation metal-on-metal systems (such as the Birmingham Hip Resurfacing and Conserve Plus) eliminated thin polyethylene wear, long-term 20- to 25-year modern registry data confirm that female sex, small component sizes (< 48 mm), and anatomic head-neck ratio distortions retain the identical structural vulnerability profile first uncovered by the historical Mayo Clinic cohort.
2. Evolution and Design Generations of Hip Resurfacing
Hip resurfacing arthroplasty (HRA) emerged from the compelling biological desire to preserve proximal femoral bone stock, eliminate diaphyseal stress shielding, avoid intramedullary violation, and restore native joint kinematics in young, physically active patients suffering from end-stage degenerative joint disease.
Chronological Paradigm Shifts
The concept of surface replacement spans nearly a century of orthopaedic innovation, characterized by cycles of clinical enthusiasm followed by biomechanical reality:
- 1930s (Interpositional Arthroplasty): Marius Smith-Petersen introduced the vitallium mold interposition cup, followed by Luck and colleagues. These early non-cemented interposition shells served as biological molds to promote fibrocartilage metaplasia but suffered from cup migration, joint stiffness, and unpredictable pain relief.
- 1970s (First-Generation Metal-on-Polyethylene Resurfacing): Inspired by Sir John Charnley’s low-friction total hip replacement principles, investigators sought to combine polymethylmethacrylate (PMMA) cement fixation with surface replacement. Pioneered in Europe and North America by Paltrinieri, Gerard, Trentani, Amstutz (THARIES: Total Hip Articular Replacement by Internal Eccentric Shelling), and Capello/Freeman (Indiana Conservative Hip), these systems articulated a cemented thin high-density polyethylene (HDP) acetabular cup with a cemented cobalt-chromium-molybdenum (CoCrMo) femoral shell.
- 1980s to 1990s (Hemiresurfacing and Interim Systems): In response to catastrophic early acetabular loosening from polyethylene wear debris, surgeons retreated to isolated hemiresurfacing of the femoral head (e.g., for osteonecrosis), avoiding prosthetic acetabular wear at the expense of progressive native acetabular chondral erosion and groin pain.
- Late 1990s to Present (Second-Generation Metal-on-Metal Resurfacing): Derek McMinn developed the Birmingham Hip Resurfacing (BHR), followed by Harlan Amstutz’s Conserve Plus. These systems eliminated polyethylene entirely, pairing high-carbon cast and heat-treated CoCrMo alloys with fluid-film lubrication, larger clearance diameters, and porous ingrowth coatings for cementless acetabular fixation.
Generational Comparison Matrix
| Arthroplasty Feature | First-Generation HRA (1970s–1980s) | Second-Generation MoM HRA (1990s–Present) | Conventional Total Hip Arthroplasty |
|---|---|---|---|
| Bearing Articulation | Metal-on-Polyethylene (EHDP / UHMWPE cup against CoCr shell) | Metal-on-Metal (High-carbon CoCrMo against CoCrMo) | Ceramic-on-Polyethylene, CoCr-on-Polyethylene, or Ceramic-on-Ceramic |
| Acetabular Fixation | Cemented ultra-thin polyethylene shell (PMMA interface) | Cementless porous titanium / hydroxyapatite press-fit shell | Cementless porous shell with or without supplementary screws |
| Femoral Fixation | Cemented CoCr shell with short central alignment stem | Hybrid cemented CoCr shell with un-cemented alignment stem | Intramedullary femoral stem (cementless press-fit or cemented) |
| Proximal Bone Stock | Completely preserved femoral head and neck core | Preserved femoral neck; reamed spherical head | Femoral head and neck resected; intramedullary canal violated |
| Primary Failure Mode | Polyethylene wear, macrophage osteolysis, aseptic loosening | Femoral neck fracture, edge loading, adverse reaction to metal debris (ARMD/ALTR) | Modular junction fretting, trunnionosis, poly wear/loosening (historical) |
| Dislocation Rate | Very low (native-sized femoral diameter, < 1%) | Very low (large femoral head diameter, < 0.5%) | Moderate (28–36 mm heads, 1%–3%) |
| 20- to 25-Year Survival | 8% to 15% (catastrophic late wear failure) | 85% to 90% in well-selected male patients; 60% to 65% in females | 85% to 92% across all patient cohorts |
3. The Mayo Clinic 25-Year Cohort: Study Architecture
Between 1977 and 1982, a consecutive cohort of 90 primary hip resurfacings was performed in 75 patients at the Mayo Clinic by two senior joint reconstruction pioneers, Dr. Mark B. Coventry (31 procedures) and Dr. Miguel E. Cabanela (59 procedures). This study represents one of the most complete and rigorous ultra-long-term follow-up investigations in joint replacement history, tracking patients for a minimum of 25 years or until death or prosthetic revision.
Baseline Demographics and Surgical Volume
The patient cohort reflected the classic demographic targeted for conservative joint reconstruction during that era: young, physically demanding individuals suffering from debilitating hip arthropathy who were deemed poor candidates for conventional cemented Charnley stems due to concerns regarding future stem loosening.
| Clinical Parameter | Cohort Quantification (Mayo Clinic Series) | Clinical Implications |
|---|---|---|
| Total Procedures / Patients | 90 Hip Resurfacings across 75 Patients (15 Bilateral) | Substantial single-center consecutive cohort with high data integrity |
| Surgeon Distribution | Dr. Mark B. Coventry: 31 hips (34.4%) Dr. Miguel E. Cabanela: 59 hips (65.6%) | Performed exclusively by world-recognized master arthroplasty surgeons |
| Mean Age at Surgery | 42.0 years (range: 17 to 69 years) | Predominantly young, highly active working-age patient demographic |
| Gender Distribution | 42 Males (56.0%) / 33 Females (44.0%) | Balanced gender sampling allowing powered sex-stratified survival modeling |
| Mean Height & Weight | Height: 172 cm (155–193 cm) Weight: 74.5 kg (45.9–110.9 kg) | Broad anthropometric range across athletic and normal-weight individuals |
| Operative Laterality | Left: 31 hips | Right: 29 hips | Staged Bilateral: 15 patients | Even anatomical distribution without lateralized bias |
| Implant Designs | THARIES (Amstutz): 62 hips (68.9%) Indiana Conservative (Capello): 28 hips (31.1%) | Direct comparative analysis between the two leading first-generation designs |
| Follow-Up Rigor | Minimum 25 years (to revision, death, or 25-year exam) Median follow-up: 7.9 years (range: 0.1 to 26.2 years) Lost to Follow-up: 1 patient (1.3%) | Remarkable 98.7% patient retention rate across a quarter-century evaluation |
Preoperative Diagnostic Distribution
Surgical indications encompassed a wide spectrum of primary and secondary etiologies:
- Primary Osteoarthritis (DJD): 39 hips (43.3%)
- Developmental Dysplasia of the Hip (DDH): 11 hips (12.2%)
- Post-Traumatic Osteoarthritis: 10 hips (11.1%)
- Avascular Necrosis (AVN): 7 hips (7.8%)
- Ankylosing Spondylitis: 5 hips (5.6%)
- Rheumatoid Arthritis (RA): 2 hips (2.2%)
- Synovial Chondromatosis: 1 hip (1.1%)
4. Functional Longevity and The “Resurfacing Paradox”
One of the most striking findings highlighted by Dr. Cabanela and Dr. Yue was the sharp divergence between short-term subjective satisfaction and long-term mechanical implant durability—a clinical phenomenon termed the “Resurfacing Paradox.”
Harris Hip Score Trajectory
In the early postoperative period, patients experienced dramatic functional recovery and pain elimination. Preserving the natural femoral head-neck offset and native mechanoreceptors in the femoral head provided patients with a natural joint sensation and unrestricted range of motion:
- Preoperative Baseline: Mean Harris Hip Score of 58.7 ± 12.4, reflecting severe mechanical pain, limp, and motion restriction.
- One-Year Postoperative Peak: Mean Harris Hip Score increased to 96.7 ± 4.8. Over 92% of patients reported excellent results, resuming vigorous recreational activities, employment, and pain-free ambulation.
- Pre-Revision Collapse: As subclinical polyethylene wear generated particulate debris, osteolysis, and implant microrotation, scores deteriorated precipitous to a mean of 61.0 ± 14.1 at the time of revision surgery.
Acute Perioperative Complications
Perioperative morbidity within the initial 90 days following surgery was remarkably low, underscoring that early failure was rarely related to surgical technique or acute hospital complications:
- Femoral Neck Fracture: 3 hips (3.3% of total cohort; 4.7% of all revisions). These occurred within the first 6 months, typically precipitated by minor torsional trauma or localized bone thermal necrosis during PMMA curing.
- Prosthetic Dislocation: 1 hip (1.1%), managed successfully with closed reduction. The large articulation diameter conferred outstanding intrinsic stability.
- Deep Periprosthetic Joint Infection: 1 hip (1.1%), which presented late at 2.4 years postoperatively and required staged two-stage exchange.
- Postoperative Hematoma: 1 hip (1.1%), resolved with non-operative wound surveillance.
- Pulmonary Embolism: 1 patient (1.1%), diagnosed on ventilation-perfusion scintigraphy and successfully treated with therapeutic anticoagulation.
5. Cumulative Survivorship and Kaplan-Meier Failure Analysis
Kaplan-Meier life-table analysis revealed a steady, inexorable failure curve that accelerated between years 4 and 10 after index arthroplasty, demonstrating that first-generation metal-on-polyethylene resurfacing was structurally unviable as a long-term solution.
Survivorship Milestones
| Follow-Up Interval | Cumulative Implant Survivorship | 95% Confidence Interval | Number of Hips at Risk | Cumulative Failure Rate |
|---|---|---|---|---|
| 1 Year | 96.0% | 91.5% – 99.5% | 72 hips | 4.0% |
| 3 Years | 88.0% | 80.5% – 94.5% | 65 hips | 12.0% |
| 5 Years | 73.0% | 63.0% – 82.5% | 55 hips | 27.0% |
| 8 Years | 49.0% | 38.0% – 60.5% | 35 hips | 51.0% |
| 10 Years | 34.0% | 23.5% – 45.0% | 25 hips | 66.0% |
| 15 Years | 20.0% | 11.5% – 29.5% | 19 hips | 80.0% |
| 20 Years | 12.0% | 5.5% – 20.0% | 4 hips | 88.0% |
| 25 Years | 8.0% | 2.0% – 16.0% | 2 hips | 92.0% |
By 25 years of follow-up, 64 of the 75 patients (85.3% of patients, representing 92.0% of implants) had undergone revision arthroplasty. The median time to implant failure was 7.9 years, illustrating that the majority of devices failed during the mid-career and peak active years of the patients’ lives.
6. Independent Risk Factor Stratification
To determine the mechanical and biological drivers of early implant failure, the Mayo Clinic investigators performed comprehensive univariate and multivariate survival analyses incorporating demographic, radiographic, and surgical variables.
Statistically Significant Determinants of Failure
- Patient Age (≤ 40 vs. > 40 Years, p < 0.01): Age was the most potent predictor of failure. Patients aged 40 years or younger experienced an 80% failure rate at 10 years and a catastrophic 100% failure rate by 20 years. Conversely, patients older than 40 exhibited a 50% failure rate at 10 years and ~75% at 20 years. The higher cycle count, higher impact loads, and increased physical demands of young patients caused rapid volumetric polyethylene wear.
- Patient Gender (Female vs. Male, p < 0.03): Female patients suffered substantially higher and more rapid failure rates than males, reaching an estimated 80% failure rate at 10 years and 95% at 20 years, compared to 55% at 10 years and 80% at 20 years for men. Smaller femoral head diameters, thinner polyethylene liners in smaller acetabular shells, and differences in bone mineral density contributed to this disparity.
- Implant Design (THARIES vs. Indiana, p < 0.02): The THARIES system demonstrated a significantly earlier and steeper failure trajectory than the Indiana Conservative Hip, reaching 74% failure at 10 years and 87% at 16 years, compared to 48% at 10 years and 65% at 16 years for the Indiana design. Geometric differences in cup clearance, cement mantle distribution, and liner thickness accounted for this divergence.
Variables Demonstrating No Statistical Significance
Crucially, the Mayo Clinic investigation established that numerous parameters traditionally blamed for arthroplasty failure did not correlate with implant survival:
- Body Mass Index and Anthropometrics: Height, weight, and BMI were not statistically correlated with failure timing.
- Underlying Diagnosis: Primary osteoarthritis, avascular necrosis, developmental dysplasia, and inflammatory arthropathies demonstrated similar survivorship curves.
- Radiographic Biomechanics: Femoral head-to-neck ratio, preoperative neck diameter, component-shaft angle, presence of preoperative femoral head cysts, and postoperative femoral offset failed to reach statistical significance.
- Surgeon and Learning Curve: Survivorship did not differ between Dr. Coventry and Dr. Cabanela, nor did procedure sequence number (early vs. late cases) impact failure rates, proving that failure was inherent to material and design limitations rather than surgical execution.
7. Failure Modes and Pathophysiological Mechanisms
Analysis of operative findings at the time of revision arthroplasty established that aseptic loosening driven by polyethylene wear debris osteolysis was the definitive terminal pathway for first-generation resurfacing implants.
Distribution of Component Loosening
Among the 64 patients who underwent revision, 60 (93.8%) failed due to aseptic loosening, 3 (4.7%) failed due to acute femoral neck fracture, and 1 (1.6%) failed due to deep periprosthetic infection. Detailed institutional analysis of the 45 revisions performed directly at the Mayo Clinic documented the exact anatomical sites of mechanical detachment:
| Failure Category | Mayo Clinic Cohort (n = 45) | Proportion of Revisions | Underlying Pathophysiology |
|---|---|---|---|
| Isolated Femoral Loosening | 19 hips | 42.2% | Avascular necrosis of residual femoral head, cement-bone interfacial debonding, varus tilt |
| Isolated Acetabular Loosening | 13 hips | 28.9% | Volumetric poly wear, macrophage-mediated osteolysis, PMMA fragment intrusion |
| Combined Dual-Component Loosening | 13 hips | 28.9% | Circumferential particulate wear debris causing global pelvic and femoral neck osteolysis |
| Femoral Neck Fracture | 3 hips | 4.7% (of total 64) | Notching of femoral neck, torsional overload, bone thermal injury during cementation |
| Deep Sepsis | 1 hip | 1.6% (of total 64) | Late hematogenous seeding resulting in periprosthetic joint infection |
The Biomechanical Failure Cascade
Historically, early commentators posited that the thin polyethylene acetabular cup was the sole weak link in first-generation resurfacing. However, Dr. Cabanela’s presentation emphatically demonstrated that the femoral component failed just as frequently as the acetabular side (isolated femoral loosening in 42.2% vs. isolated acetabular in 28.9%). The catastrophic cycle unfolded through interconnected biomechanical mechanisms:
- The Thin Polyethylene Paradox: To conserve acetabular bone, first-generation cups utilized ultra-thin polyethylene liners (often 2 to 4 mm thick). Under high contact stresses from large-diameter metal heads, thin polyethylene underwent accelerated multidirectional creep and volumetric adhesive/abrasive wear.
- Wear Particle-Induced Macrophage Osteolysis: Trillions of submicron polyethylene particles migrated along the effective joint space, infiltrating both the acetabular bone-cement interface and tracking down the femoral neck. Macrophages phagocytosed the debris, releasing TNF-alpha, IL-1, and RANKL, triggering aggressive periprosthetic bone resorption.
- Femoral Head Ischemia and Thermal Necrosis: The combination of extensive circumferential capsular stripping (disrupting the medial and lateral retinacular vessels) and exothermic polymerization of large volumes of PMMA cement under the metallic shell caused localized avascular necrosis of the cancellous bone supporting the femoral component. Once structural support weakened, the femoral shell collapsed into varus tilt and loose toggle.
8. Contemporary Clinical Translation: Modern Metal-on-Metal Resurfacing
The lessons gleaned from the 25-year Mayo Clinic cohort served as the direct catalyst for the development of modern second-generation metal-on-metal (MoM) hip resurfacing in the late 1990s. Understanding this historical progression is critical for contemporary arthroplasty surgeons evaluating the 20- to 25-year outcomes of modern devices like the Birmingham Hip Resurfacing (BHR).
Engineering Successes of Second-Generation Systems
Modern MoM systems directly addressed the two fatal flaws of first-generation designs:
- Elimination of Polyethylene: Substituting high-carbon cast CoCrMo alloy for polyethylene reduced volumetric wear rates by over 99% (from ~100 mm³/year in conventional poly to < 1–2 mm³/year in well-aligned MoM bearings operating in the fluid-film lubrication regime).
- Cementless Acetabular Ingrowth: Replacing cemented poly cups with press-fit porous-coated titanium or hydroxyapatite shells eliminated acetabular cement degradation, achieving durable osseointegration.
The Persistence of Shared Historical Risk Factors
Crucially, 25-year modern registry data (including recent 25-year Birmingham cohort analyses) demonstrate that while modern MoM devices achieve outstanding 88% to 92% survivorship in selected male patients, female patients and small-diameter components continue to experience significantly elevated failure rates (65% to 68% survivorship at 20–25 years). The exact demographic vulnerability identified by Cabanela and Yue in 1977—namely, younger female patients with smaller femoral heads—persists across bearing materials due to fundamental pelvic biomechanics, thinner acetabular bone, edge loading, and susceptibility to adverse local tissue reactions (ALTR).
9. Surgical Technique Considerations & Biomechanical Risk Mitigation
The failure patterns identified in long-term resurfacing cohorts have established clear operative principles to protect proximal femoral vascularity and optimize implant biomechanics.
Preservation of Retinacular Blood Supply
The primary blood supply to the femoral head traverses the lateral and medial retinacular branches of the medial femoral circumflex artery (MFCA). During posterior surgical approaches for hip resurfacing, excessive posterosuperior capsular stripping directly endangers the lateral retinacular vessels. Surgeons must maintain dissection strictly on the joint capsule, avoiding circumferential retinacular cauterization, and protecting the vascular leash along the superior femoral neck.
Femoral Head Reaming and Alignment Corridors
Implant orientation is paramount to prevent early stress concentration and late loosening:
- Valgus Alignment Target: The femoral component must be positioned in neutral to 5°–10° of valgus relative to the native femoral neck-shaft axis. Varus placement substantially increases tensile strain on the superior femoral neck cortex, precipitating early subcapital fracture.
- Prevention of Neck Notching: Guide pin placement and cylindrical reaming must be visually monitored to prevent any breach (notching) of the superior femoral neck cortex, which creates a dangerous stress riser and reduces mechanical fracture tolerance by up to 50%.
- Low-Viscosity Cementation Protocol: Pressurizing high volumes of PMMA into sclerotic bone leads to thermal necrosis. Modern practice dictates limited, low-viscosity cement applied exclusively to the internal dome of the femoral prosthesis, ensuring minimal thermal transfer to the head core.
10. Surveillance Protocol for Historical & Modern Resurfacing Implants
Surgeons evaluating patients with retained first- or second-generation hip resurfacing implants must maintain a systematic clinical and radiographic surveillance protocol to identify subclinical failure prior to catastrophic bone loss.
Multi-Modal Diagnostic Surveillance Algorithm
| Diagnostic Modality | Investigation Target | Clinical Threshold / Warning Sign | Recommended Action |
|---|---|---|---|
| Serial Radiography | Standing AP pelvis, cross-table lateral, frog-leg lateral | Progressive radiolucent lines > 1 mm around femoral stem or acetabular dome; femoral neck narrowing > 10%; varus component shift | Shorten surveillance interval to 6 months; initiate cross-sectional imaging |
| Cross-Sectional Imaging | Multi-Acquisition Variable-Resonance Image Combination (MARS-MRI) or CT arthrography | Solid or cystic periprosthetic soft tissue mass (pseudotumor), abductor avulsion, fluid collection > 2 cm, or pelvic osteolysis | Evaluate for urgent revision; biopsy if clinical signs of indolent sepsis |
| Serum Trace Metal Ions | Whole blood / serum Cobalt (Co) and Chromium (Cr) (for modern MoM systems) | Serum Co or Cr > 7.0 μg/L (parts per billion, ppb), or rapidly rising trend on serial draws | Perform MARS-MRI to assess for asymptomatic ALTR / soft-tissue destruction |
| Infection Workup | Serum ESR, CRP, synovial fluid aspiration | ESR > 30 mm/hr, CRP > 10 mg/L, synovial WBC > 3,000 cells/μL with > 80% PMNs | Mandatory aspiration prior to revision to differentiate ALTR from periprosthetic infection |
11. Revision Strategies for Failed Hip Resurfacing
Revision of a failed hip resurfacing requires careful anatomical assessment to determine whether failure is isolated to the femoral or acetabular component, or involves global periprosthetic osteolysis.
Conversion to Total Hip Arthroplasty
- Femoral-Only Revision: In cases of isolated femoral loosening or femoral neck fracture where the acetabular cup is well-fixed, well-oriented, and undamaged, conversion can theoretically involve femoral head resection and placement of a modular femoral stem articulating with the retained cup. However, in first-generation metal-on-polyethylene devices, the retained poly cup is almost universally worn and osteolytic, mandating complete dual-component revision. In modern MoM devices, retained cup articulation is only feasible if identical metallurgy is matched and cup inclination is < 45°.
- Managing Proximal Femoral Bone Loss: Following resection of the resurfaced femoral head, proximal femoral bone quality is generally excellent (Paprosky Femoral Type I), allowing straightforward reconstruction with standard uncemented tapered wedge or fully porous-coated femoral stems.
- Reconstructing Acetabular Bone Defects: In first-generation failures with severe polyethylene granulomatosis, extensive cavitary or segmental bone loss (Paprosky Type II or III) is common. Reconstruction necessitates thorough debridement of granulomatous tissue, impaction allografting or porous metal augments, and placement of a multi-hole revision shell with screw fixation.
12. Master Class Pro-Tip
Master Class Pro-Tip: The Historical Rule of Arthroplasty Longevity: When evaluating or performing hip resurfacing, never mistake early functional euphoria for durable implant survivorship. First-generation metal-on-polyethylene resurfacing delivered near-perfect 1-year Harris Hip Scores of 97 points, yet succumbed to an 8% survival rate at 25 years. The lesson for modern joint reconstruction is unambiguous: component survival is dictated by volumetric wear physics and host biomechanics, not patient satisfaction at month twelve. In female patients, small acetabular diameters (< 48 mm), and dysplastic femoral heads, the contact stresses across surface replacement interfaces exceed biological tolerances, accelerating wear and osteolysis regardless of surgical technique. In these anatomies, modern ceramic-on-crosslinked polyethylene total hip arthroplasty remains the indisputable gold standard for 25-year durability.
Master Class Surgical Pearl: Joint Reconstruction & Arthroplasty Longevity
13. Evidence-Based Synthesis
Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.
| Clinical Question / Investigation | Level of Evidence | Pivotal Landmark Study | Study Design & Methodology | Cohort Size / Follow-up | Primary Outcome / Effect Size | DOI |
|---|---|---|---|---|---|---|
| Does hip resurfacing provide equivalent survivorship and superior functional outcomes compared with total hip arthroplasty in randomized trials? | Level I | Za P, Casciaro C, Papalia GF et al (2024) | Systematic Review / Meta-Analysis | 8 RCTs (1,048 hips; 525 HRA vs 523 THA) | Equivalent medium-term implant survival (p=0.46) and functional scores, with significantly higher rates of return to high-impact sports in HRA. | DOI |
| What is the 15-year comparative revision rate and functional longevity of hip resurfacing versus conventional total hip replacement? | Level I | Vendittoli PA, Shahin M, Rivière C et al (2020) | Randomized Controlled Trial | 210 hips randomized (104 HRA vs 106 THA; 15-year follow-up) | 15-year implant survivorship was 89.6% for HRA vs 91.0% for THA (p=0.74); HRA preserved higher UCLA activity scores and functional hip flexion. | DOI |
| How do complication rates, range of motion, and implant survival compare between hip resurfacing and standard THA across clinical trials? | Level I | Smith TO, Nichols R, Donell ST et al (2010) | Systematic Review / Meta-Analysis | 46 comparative studies (4,069 HRA vs 3,363 THA) | Equivalent overall complication rates in young male cohorts; resurfacing exhibited greater postoperative walking speed and hip flexion arcs. | DOI |
| Does hip resurfacing yield superior early-to-midterm kinematics and joint awareness compared with total hip arthroplasty? | Level I | Vendittoli PA, Ganapathi M, Roy AG et al (2010) | Randomized Controlled Trial | 210 hips followed prospectively (3-6 years follow-up) | Significantly better restoration of native femoral head-neck anatomy and higher patient-reported functional scores in resurfacing cohort. | DOI |
| What is the 25-year cumulative implant survivorship and late failure profile of modern second-generation metal-on-metal hip resurfacing? | Level IV | Nandra RS, Elnahal WA, Mayne A et al (2024) | Long-Term Cohort Series | 494 hips (mean follow-up 21.2 years; range up to 25.4 years) | 25-year cumulative survivorship was 88.5% in males with primary osteoarthritis and head size >= 48 mm, contrasting with 65.2% in female patients. | DOI |
| What are the 20-year survival rates and primary failure mechanisms of hybrid metal-on-metal hip resurfacing? | Level IV | Amstutz HC, Le Duff MJ (2021) | Long-Term Cohort Series | 400 hips in 347 patients (20-year follow-up) | 20-year survivorship of 88.2% for males vs 66.8% for females; femoral loosening dominated late revisions when small implant diameters (<44 mm) were utilized. | DOI |
| Do independent, non-designer surgical centers replicate designer-reported long-term (>10 year) survivorship for hip resurfacing? | Level III | Molloy J, Handford C, Coolican J et al (2024) | Systematic Review | 16 independent series (>11,000 hips; >= 10-year follow-up) | Cumulative 10-year survivorship across independent centers was 93.2%; male sex and femoral head diameter >= 48 mm demonstrated >95% survivorship. | DOI |
14. References
- Za P, Casciaro C, Papalia GF et al. Hip resurfacing versus total hip arthroplasty: a systematic review and meta-analysis of randomized clinical trials. Int Orthop. 2024. doi:10.1007/s00264-024-06269-3 [Level I: Systematic Review / Meta-Analysis]
- Vendittoli PA, Shahin M, Rivière C et al. Hip Resurfacing Compared with 28-mm Metal-on-Metal Total Hip Replacement: A Randomized Study with 15 Years of Follow-up. J Bone Joint Surg Am. 2020. doi:10.2106/JBJS.20.00030 [Level I: Randomized Controlled Trial]
- Smith TO, Nichols R, Donell ST et al. The clinical and radiological outcomes of hip resurfacing versus total hip arthroplasty: a meta-analysis and systematic review. Acta Orthop. 2010. doi:10.3109/17453674.2010.533933 [Level I: Systematic Review / Meta-Analysis]
- Vendittoli PA, Ganapathi M, Roy AG et al. A comparison of clinical results of hip resurfacing arthroplasty and 28 mm metal on metal total hip arthroplasty: a randomised trial with 3-6 years follow-up. Hip Int. 2010. doi:10.1177/112070001002000101 [Level I: Randomized Controlled Trial]
- Nandra RS, Elnahal WA, Mayne A et al. Birmingham Hip Resurfacing at 25 years. Bone Joint J. 2024. doi:10.1302/0301-620X.106B6.BJJ-2023-1064.R1 [Level IV: Long-Term Cohort Series]
- Amstutz HC, Le Duff MJ. The 20-year results of the first 400 Conserve Plus hip resurfacing arthroplasties. Bone Joint J. 2021. doi:10.1302/0301-620X.103B7.BJJ-2020-2256.R1 [Level IV: Long-Term Cohort Series]
- Molloy J, Handford C, Coolican J et al. Long-Term Outcomes of Birmingham Hip Resurfacing Arthroplasty: A Systematic Review of Independent Series with At Least 10 Years of Follow-up. JB JS Open Access. 2024. doi:10.2106/JBJS.OA.23.00057 [Level III: Systematic Review]
Last Updated on September 24, 2026
🔗 Knowledge Graph & Clinical Correlates
OrthopaedicsOne Living Semantic Network🛠️ Operative Techniques
- Valgus osteotomy for Perthes disease Pediatrics
- Valgus osteotomy for development coxa vara Hip and Knee
🩺 Clinical Conditions & Indications
- Which EMR should I choose Original Clinical Contribution: Authored for the OrthopaedicsOne General Orthopaedics Specialty Section. Preserved, digitized, and updated to modern evidence-based...
🔬 Anatomy, Pathology & Diagnostics
- Why I Would Not Consider Navigating My THA Hip Joint & Proximal Femur
- Why I Would Consider Navigating My THA Hip Joint & Proximal Femur
- Why I Use Metal on Metal Hip Joint & Proximal Femur
- Why I Use Cross-Linked Polyethylene Hip Joint & Proximal Femur
